US Patent 10400039 Targeted binding agents against B7-H1
Patent 10400039 was granted and assigned to Medimmune Limited on September, 2019 by the United States Patent and Trademark Office.
Something went wrong.
Try refreshing the page.
Find more entities like US Patent 10400039 Targeted binding agents against B7-H1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
